Dekamycin V: Full Drug Profile
Dekamycin V - General Information
A component of neomycin that is produced by Streptomyces fradiae. On hydrolysis it yields neamine and neobiosamine B. (From Merck Index, 11th ed)
Pharmacology of Dekamycin V
Dekamycin V is used for the treatment of bacterial eye infections such as conjunctivitis. Dekamycin V is an antibiotic. It is not active against fungi, viruses and most kinds of anaerobic bacteria. Dekamycin V works by binding to the bacterial 30S ribosomal subunit, causing misreading of t-RNA, leaving the bacterium unable to synthesize proteins vital to its growth. Dekamycin V is useful primarily in infections involving aerobic bacteria bacteria.
Additional information about Dekamycin V
- Dekamycin V Indication
For the treatment of bacterial blepharitis, bacterial bonjunctivitis, corneal injuries, corneal ulcers and meibomianitis. For the prophylaxis of ocular infections following foreign body removal
- Mechanism Of Action
- Dekamycin V binds to specific 30S-subunit proteins and 16S rRNA, four nucleotides of 16S rRNA and a single amino acid of protein S12. This interferes with decoding site in the vicinity of nucleotide 1400 in 16S rRNA of 30S subunit. This region interacts with the wobble base in the anticodon of tRNA. This leads to interference with the initiation complex, misreading of mRNA so incorrect amino acids are inserted into the polypeptide leading to nonfunctional or toxic peptides and the breakup of polysomes into nonfunctional monosomes.
- Generic Name
- Framycetin
- Synonyms
- Framycetinum [Inn-Latin]; Neomycin B; Streptothricin B
- Drug Category
- Anti-Bacterial Agents; Antibiotics
- Drug Type
- Small Molecule; Approved
- Other Brand Names containing Framycetin
- Actilin; Actiline; Antibiotique; Dekamycin V; Enterfram; Fradiomycin B; Framygen; Nebramycin X; Negamicin; Neomycin A; Soframycin; Soframycin Ophthalmic; Soframycine;
- Dosage Forms of Dekamycin V
- Solution / drops Ophthalmic
- Chemical IUPAC Name
- (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
- Chemical Formula
- C23H46N6O13
- Organisms Affected
- Enteric bacteria and other eubacteria
